Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 279

1.

Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.

Michaud TL, Abraham J, Jalal H, Luepker RV, Duval S, Hirsch AT.

J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002321. doi: 10.1161/JAHA.115.002321.

2.

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey.

Luepker RV, Steffen LM, Duval S, Zantek ND, Zhou X, Hirsch AT.

J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002320. doi: 10.1161/JAHA.115.002320.

3.

Falling Coronary Heart Disease Rates: A Better Explanation?

Luepker RV.

Circulation. 2016 Jan 5;133(1):8-11. doi: 10.1161/CIRCULATIONAHA.115.019862. Epub 2015 Nov 18. No abstract available.

PMID:
26582782
4.

Vital exhaustion: ready for prime time?

Luepker RV, Charles Schulz S.

Eur Heart J. 2015 Jun 7;36(22):1361-3. doi: 10.1093/eurheartj/ehv065. Epub 2015 Mar 22. No abstract available.

5.

The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry.

Duval S, Keo HH, Oldenburg NC, Baumgartner I, Jaff MR, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT.

Am Heart J. 2014 Oct;168(4):577-87. doi: 10.1016/j.ahj.2014.06.013. Epub 2014 Jun 24.

PMID:
25262269
6.

Acute stroke reperfusion therapy trends in the expanded treatment window era.

Asaithambi G, Tong X, George MG, Tsai AW, Peacock JM, Luepker RV, Lakshminarayan K.

J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2316-21. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.023. Epub 2014 Aug 23.

7.

Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.

Vakil K, Taimeh Z, Sharma A, Abidi KS, Colvin M, Luepker R, Levy WC, Adabag S.

Heart Rhythm. 2014 Oct;11(10):1684-90. doi: 10.1016/j.hrthm.2014.07.016. Epub 2014 Jul 15.

PMID:
25048441
8.

Trends in 10-year survival of patients with stroke hospitalized between 1980 and 2000: the Minnesota stroke survey.

Lakshminarayan K, Berger AK, Fuller CC, Jacobs DR Jr, Anderson DC, Steffen LM, Sillah A, Luepker RV.

Stroke. 2014 Sep;45(9):2575-81. doi: 10.1161/STROKEAHA.114.005512. Epub 2014 Jul 15.

9.

A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.

Oldenburg NC, Duval S, Luepker RV, Finnegan JR, LaMarre H, Peterson KA, Zantek ND, Jacobs G, Straka RJ, Miller KH, Hirsch AT.

Prev Chronic Dis. 2014 May 15;11:E83. doi: 10.5888/pcd11.130378.

10.

The FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease.

Keo HH, Duval S, Baumgartner I, Oldenburg NC, Jaff MR, Goldman J, Peacock JM, Tretinyak AS, Henry TD, Luepker RV, Hirsch AT.

BMC Cardiovasc Disord. 2013 Dec 19;13:120. doi: 10.1186/1471-2261-13-120.

11.

Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes.

Ellrodt AG, Fonarow GC, Schwamm LH, Albert N, Bhatt DL, Cannon CP, Hernandez AF, Hlatky MA, Luepker RV, Peterson PN, Reeves M, Smith EE.

Circulation. 2013 Nov 26;128(22):2447-60. doi: 10.1161/01.cir.0000435779.48007.5c. Epub 2013 Oct 28. No abstract available.

12.

Twenty-two-year population trends in sodium and potassium consumption: the Minnesota Heart Survey.

Meyer KA, Harnack LJ, Luepker RV, Zhou X, Jacobs DR, Steffen LM.

J Am Heart Assoc. 2013 Oct 2;2(5):e000478. doi: 10.1161/JAHA.113.000478.

13.

International comparison of treatment and long-term outcomes for acute myocardial infarction in the elderly: Minneapolis/St. Paul, MN, USA and Goteborg, Sweden.

Smith LG, Herlitz J, Karlsson T, Berger AK, Luepker RV.

Eur Heart J. 2013 Nov;34(41):3191-7. doi: 10.1093/eurheartj/eht196. Epub 2013 Jun 25.

14.

CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.

Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.

Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

PMID:
23739192
15.

Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.

Zantek ND, Luepker RV, Duval S, Miller K, Oldenburg N, Hirsch AT.

Clin Appl Thromb Hemost. 2014 May;20(4):385-92. doi: 10.1177/1076029613486537. Epub 2013 May 7.

PMID:
23653145
16.

Cigarette smoking and cardiovascular disease: lessons from framingham.

Filion KB, Luepker RV.

Glob Heart. 2013 Mar;8(1):35-41. doi: 10.1016/j.gheart.2012.12.005. Epub 2013 Mar 15.

PMID:
25690262
17.

The "heart disease and stroke statistics--2013 update" and the need for a national cardiovascular surveillance system.

Sidney S, Rosamond WD, Howard VJ, Luepker RV; National Forum for Heart Disease and Stroke Prevention.

Circulation. 2013 Jan 1;127(1):21-3. doi: 10.1161/CIRCULATIONAHA.112.155911. Epub 2012 Dec 13. No abstract available.

18.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
19.

Dental procedures and risk of experiencing a second vascular event in a Medicare population.

Skaar D, O'Connor H, Lunos S, Luepker R, Michalowicz BS.

J Am Dent Assoc. 2012 Nov;143(11):1190-8.

PMID:
23115147
20.

Sudden cardiac death in heart failure patients with preserved ejection fraction.

Adabag S, Smith LG, Anand IS, Berger AK, Luepker RV.

J Card Fail. 2012 Oct;18(10):749-54. doi: 10.1016/j.cardfail.2012.08.357.

PMID:
23040109
Items per page

Supplemental Content

Loading ...
Write to the Help Desk